Initial Rate of BCR::ABL1 Decline for Response Prediction in Chronic Myeloid Leukemia

Turk J Haematol. 2022 Aug 25;39(3):204-205. doi: 10.4274/tjh.galenos.2022.2022.0247. Epub 2022 Jun 14.

Author

Susan Branford^{1

2

3}

Affiliations

¹ Centre for Cancer Biology, SA Pathology, Adelaide, Australia
² University of South Australia, School of Pharmacy and Medical Science, Adelaide, Australia
³ University of Adelaide, School of Medicine, Adelaide, Australia

No abstract available

MeSH terms

Fusion Proteins, bcr-abl / genetics
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / diagnosis
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / genetics
Leukemia, Myeloid*
Protein Kinase Inhibitors / therapeutic use

Substances

Protein Kinase Inhibitors
Fusion Proteins, bcr-abl